Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9–12 months after treatment

BACKGROUND: Papillary thyroid cancer (PTC) has an excellent prognosis, and recurrence is rare in patients with no evidence of disease (NED) after initial treatment. Despite this, several guidelines recommend long and costly follow-up, with limited evidence of improved patient outcomes. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordell, Fabian, Hallal, Ghadir, Asp, Pernilla, Almquist, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659350/
https://www.ncbi.nlm.nih.gov/pubmed/34882764
http://dx.doi.org/10.1093/bjsopen/zrab119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659350/
https://www.ncbi.nlm.nih.gov/pubmed/34882764
http://dx.doi.org/10.1093/bjsopen/zrab119

Ejemplares similares